In vitro culture of human acute lymphoblastic leukemia (ALL) cells in serum-free media; a comparison of native ALL blasts, ALL cell lines and virus-transformed B cell lines

Leukemia Research

Volumn 27, Issue 5, 2003, Pages 455-464

  Bruserud, Øystein ^a   Glenjen, Nils ^a   Ryningen, Anita ^a   Ulvestad, Elling ^b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Acute lymphoblastic leukemia; In vitro culture; Serum free media

Indexed keywords

FLT3 LIGAND; INTERLEUKIN 7; STEM CELL FACTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B LYMPHOCYTE; BLAST CELL; CELL CULTURE; CELL PROLIFERATION; COMPARATIVE STUDY; CULTURE MEDIUM; EXPERIMENTAL MODEL; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; PRIORITY JOURNAL; VIRUS CELL TRANSFORMATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; B-LYMPHOCYTES; CELL LINE, TRANSFORMED; COCULTURE TECHNIQUES; CULTURE MEDIA; CULTURE MEDIA, SERUM-FREE; CULTURE TECHNIQUES; FEMALE; FIBROBLASTS; HUMANS; INTERLEUKINS; LEUKEMIA, B-CELL, ACUTE; LEUKEMIA, CALLA-POSITIVE; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, PRE-B-CELL; LEUKEMIA, T-CELL, ACUTE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; STEM CELL FACTOR; TUMOR CELLS, CULTURED; TUMOR STEM CELLS;

EID: 0037400596     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(02)00227-8     Document Type: Article

References (33)

1. Hoelzer D., Gokbuget N. Recent approaches in acute lymphoblastic leukemia in adults. Crit. Rev. Oncol. Hematol. 36:2000;49-58.
2. Berman E. Recent advances in the treatment of acute leukemia: 1999. Curr. Opin. Hematol. 7:2000;205-211.
3. Cortes J.E., Kantarjian H., Freireich E.J. Acute lymphoblastic leukemia: a comprehensive review with emphasis on biology and therapy. Cancer Treat. Res. 84:1996;291-323.
4. Shao L.-E., Dialynas D.P., Yu A.L., Mackintosh E., Yu J. Human cord blood conditioned medium enhances leukemia colony formation in vitro. Leuk. Res. 24:2000;1041-1048.
5. Pontvert-Delucq S., Hibner U., Vilmer E., Baillou C., Rohrlich P., Heymann D.et al. Heterogeneity of B lineage acute lymphoblastic leukemias (B-ALL) with regard to their in vitro spontaneous proliferation, growth factor response and BCL-2 expression. Leuk. Lymphoma. 21:1996;267-280.
6. Srivannaboon K., Shanafelt A.B., Todisco E., Forte C.P., Behm F.G., Raimondi S.C.et al. Interleukin 4 variant (BAY 36-1677) selectively induces apoptosis in acute lymphoblastic leukemia cells. Blood. 97:2001;752-758.
7. Köhler T., Plettig R., Wetzstein W., Schmitz M., Ritter M., Mohr B.et al. Cytokine-driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells. Stem Cells. 18:2000;139-147.
8. Duyn A.E.J., Kaspers G.J.L., Pieters R., van Zantwijk C.H., Broekema G.J., Hählen K.et al. Effects of interleukin 3, interleukin 7, and B-cell growth factor on proliferation and drug resistance in vitro in childhood acute lymphoblastic leukemia. Ann. Haematol. 78:1999;163-171.
9. Manabe A., Coustan-Smith E., Behm F.G., Raimondi S.C., Campara D. Bone marrow derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. Blood. 79:1992;2370-2377.
10. Bruserud Ø., Frostad S., Foss B. In vitro culture of acute myelogenous leukemia blasts: a comparison of four different culture media. J. Hematother. 8:1999;63-73.
11. Bradstock K.F., Makrynikola V., Bianchi A., Shen W., Hewson J., Gottlieb D.J. Effects of the chemokine stromal cell-derived factor-1 on the migration and localization of precursor-B acute lymphoblastic leukemia ells within the bone marrow. Leukemia. 14:2000;882-888.
12. Petrucci M.T., de Felice L., Riccardi M.R., Ariola C., Mascolo M.G., Fenu S.et al. Stem cell factor and PIXY-321 is acute lymphoblastic leukemia: in vitro study on proliferation effects and apoptosis. Cytokines Mol. Ther. 2:1996;225-230.
13. Eder M., Hemmati P., Kalina U., Ottman O.G., Höltzer D., Lyman S.D.et al. Effects of Flt3-L and interleukin 2 on in vitro growth of acute lymphoblastic leukemia cells. Exp. Hematol. 24:1996;371-377.
14. Campana D., Coustan-Smith E., Kumagai M.A., Manabe A. Growth requirements of normal and leukemic human B cell progenitors. Leuk. Lymphoma. 13:1994;359-371.
15. Eder M., Ottmann O.G., Hansen-Hagge T.E., Bartram C.R., Falk S., Gillis S.et al. In vitro culture of common acute lymphoblastic leukemia blasts: effects of interleukin 3, interleukin 7 and accessory cells. Blood. 79:1992;3274-3284.
16. Makrynikola V., Kabral A., Bradstock K.F. Effects of recombinant human cytokines on precursor-B acute lymphoblastic leukemia cells. Exp. Hematol. 19:1991;674-679.
17. Buske C., Hiddemann W., Wormann B. Proliferation of human leukemic pre-B cells induced by human bone marrow stromal cells and murine fibroblasts. Cell Biol. Int. 18:1994;1049-1058.
18. Fortney J.E., Zhao W., Wenger S.L., Gibson L.F. Bone marrow stromal cells regulate caspase 3 activity in leukemic cells during chemotherapy. Leuk. Res. 25:2001;901-907.
19. Bradstock K., Bianchi A., Makrynikola V., Filshie R., Gottlieb D. Long-term survival and proliferation of precursor-B acute lymphoblastic leukemia cells on human bone marrow stroma. Leukemia. 10:1996;813-820.
20. Ashley D.M., Bol S.J., Kannourakis G. Viable bone marrow stromal cells are required for the in vitro survival of B-cell precursors acute lymphoblastic leukemic cells. Leuk. Res. 19:1995;113-120.
21. Bene M.C., Castoldi G., Knapp W., Ludwig W.D., Matutes E., Orfao A.et al. Proposals for the immunological classification of acute leukemias. Leukemia. 9:1995;1783-1786.
22. Bruserud Ø., Gjertsen B.T., von Volkman H.L. In vitro culture of acute myelogenous leukemia (AML) cells in serum-free media: studies of native AML blasts and AML cell lines. J. Hematother. Stem. Cell Res. 9:2000;923-932.
23. Bruserud Ø. Effects of dipyridamole, theophyllamine and verapamil on spontaneous proliferation of myelogenous leukemia cells. Acta Oncol. 31:1992;53-58.
24. Bruserud Ø., Gjertsen B.T., Brustugun O.T., Bassoe C.F., Akselsen P.E., Bühring H.J.et al. Effect of interleukin 10 on blast cells derived from patients with acute myelogenous leukemia. Leukemia. 9:1995;1910-1920.
25. Bruserud Ø. Effects of interleukin 13 on cytokine secretion by human acute myelogenous leukemia blasts. Leukemia. 10:1996;1497-1503.
26. Bruserud Ø., Gjertsen B.T., Foss B., Huang T.S. New strategies in the treatment of acute myelogenous leukemia (AML): in vitro culture of AML cells - the present use in experimental studies and the possible importance for future therapeutic strategies. Stem. Cells. 19:2001;1-11.
27. Bruserud Ø., Ulvestad E. Acute myelogenous leukemia blasts as accessory cells during in vitro T lymphocyte activation. Cell Immunol. 206:2000;36-50.
28. Abrahamsen J.F., Bakken A.M., Bruserud Ø., Gjertsen B.T. Flow cytometric measurement of apoptosis and necrosis in cryopreserved PBPC concentrates from patients with malignant diseases. Bone Marrow Transplant. 29:2002;165-171.
29. Sissolak G., Hoffbrand A.V., Mehta A.B., Ganeshaguru K. Effects of interferon (IFN) alpha on the expression of interleukin 1 beta (IL1), interleukin 6, granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor alpha (TNF) in acute myeloid leukemia blasts. Leukemia. 6:1992;1155-1160.
30. Fiedler W., Suciu E., Wittlief C., Ostertag W., Hossfeld D.K. Mechanisms of growth factor expression in acute myeloid leukemia (AML). Leukemia. 4:1990;459-461.
31. Espinoza-Hernandez L., Cruz-Rico J., Benitez-Aranda H., Martinez-Jaramillo G., Rodriguez-Zepeda M.C., Velez-Ruelas M.A.et al. In vitro characterization of the hematopoietic system in pediatric patients with acute lymphoblastic leukemia. Leukemia Res. 25:2001;295-303.
32. Bloch A. Dynamics of interaction between DNA-specific antitumor agents and serum-contained cytokines in the initiation of ML-1 human myeloblastic leukemia cell differentiation. Leukemia. 7:1993;1219-1224.
33. Kebelmann-Betzing C., Korner G., Badiali L., Buchwald D., Moricke A., Korte A.et al. Characterization of cytokine, growth factor receptor, costimulatory and adhesion molecule expression patterns of bone marrow blasts in relapsed childhood B cell precursor ALL. Cytokine. 13:2001;39-50.